title: Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chains.
abstract: OBJECTIVE
  The objective of this study was to define the spectrum of TCR beta chains permissive for T cells with alpha chains containing the conserved TRAV5D-4*04 sequence to target the insulin B:9-23 peptide, a major epitope for initiation of diabetes in the NOD mouse.
  
  
  METHODS
  We produced T cell hybridomas from mice with single T cell receptors (BDC12-4.1 TCR alpha(+)beta(+) double transgenic mice and BDC12-4.4 TCR alpha(+)beta(+) double retrogenic mice) or from mice with only the corresponding alpha chains transgene or retrogene and multiple endogenous TCR beta chains.
  
  
  RESULTS
  Hybridomas with the complete BDC12-4.1 and BDC12-4.4 T cell receptors, despite having markedly different TCR beta chains, responded to similar B:9-23 peptides. Approximately 1% of the hybridomas from mice with the fixed TRAV5D-4*04 alpha chains and multiple endogenous beta chains responded to B:9-23 peptides while the majority of hybridomas with different beta chains did not respond. There was no apparent conservation of TCR beta chain sequences in the responding hybridomas.
  
  
  CONCLUSIONS
  Approximately 1% of hybridomas utilizing different TCR beta chains paired with the conserved TRAV5D-4*04 containing alpha chains respond to insulin peptide B:9-23. Therefore, TCR beta chain sequences make an important contribution to insulin B:9-23 peptide recognition but multiple beta chain sequences are permissive for recognition.
authors.affiliation: Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO 80045, USA.
authors.forename: Li
authors.initials: L
authors.lastname: Zhang
authors.forename: Jean M
authors.initials: JM
authors.lastname: Jasinski
authors.forename: Masakazu
authors.initials: M
authors.lastname: Kobayashi
authors.forename: Bennett
authors.initials: B
authors.lastname: Davenport
authors.forename: Kelly
authors.initials: K
authors.lastname: Johnson
authors.forename: Howard
authors.initials: H
authors.lastname: Davidson
authors.forename: Maki
authors.initials: M
authors.lastname: Nakayama
authors.forename: Kathryn
authors.initials: K
authors.lastname: Haskins
authors.forename: George S
authors.initials: GS
authors.lastname: Eisenbarth
mesh_terms: D000818:Animals; D001324:Autoantigens / Q000276:immunology; D017124:Conserved Sequence / Q000235:genetics / Q000276:immunology; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics* / Q000276:immunology / Q000473:pathology; D018604:Epitope Mapping; D006825:Hybridomas; D016056:Immunodominant Epitopes / Q000276:immunology* / Q000378:metabolism; D007328:Insulin / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D016688:Mice, Inbred NOD; D008822:Mice, Transgenic; D010446:Peptide Fragments / Q000276:immunology* / Q000378:metabolism; D011485:Protein Binding; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D037182:T-Cell Antigen Receptor Specificity / Q000235:genetics; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism* / Q000473:pathology
chemical_list: D001324:Autoantigens; D016056:Immunodominant Epitopes; D007328:Insulin; D010446:Peptide Fragments; D016693:Receptors, Antigen, T-Cell, alpha-beta; C097877:insulin B (9-23)